NT-proBNP in Hospital & Ambulatory Settings: Evidence to Clinical Practice

Webinar

Cardiology CME/CE Webinar

Natriuretic peptide clinical practice

NT-proBNP ambulatory setting

NT-proBNP hospital setting

Dr Li Yi-Heng Cardiologist, National Cheng Kung University Hospital, Taiwan

Dr James L Januzzi Cardiologist, Massachusetts General Hospital. Prof of Medicine, Harvard Medical School

17 September 2020

Key Takeaways

Biomarkers play a useful role in the comprehensive management of patients with Heart Failure
NT-proBNP is used in Emergency Departments, ward and outpatient setting
In the era of ARNi, NT-proBNP is more useful than BNP for monitoring treatment

入院および外来の現場におけるNT-proBNP：臨床診療のエビデンス

Education & CME

Webinar

入院の現場におけるNT-proBNP

外来の現場におけるNT-proBNP

臨床診療におけるナトリウム利尿ペプチド

Dr Li Yi-Heng Cardiologist, National Cheng Kung University Hospital, Taiwan

Dr James L Januzzi Cardiologist, Massachusetts General Hospital. Prof of Medicine, Harvard Medical School

17 September 2020

Key Takeaways

バイオマーカーは、心不全患者の包括的な管理において有用な役割を果たします。
NT-proBNPは、救急科、病棟および外来で使用されます。
ARNiの時代では、治療の経過観察において、脳性ナトリウム利尿ペプチド (BNP) よりもNT-proBNPの方が有用です。

입원 및 외래 환경에서의 NT-proBNP: Clinical Practice의 근거

Webinar

교육 & CME

NT-proBNP 외래 환경

NT-proBNP 입원 환경

나트륨이뇨 펩티드 임상 진료

Dr Li Yi-Heng Cardiologist, National Cheng Kung University Hospital, Taiwan

Dr James L Januzzi Cardiologist, Massachusetts General Hospital. Prof of Medicine, Harvard Medical School

17 September 2020

Key Takeaways

생체표지자는 심부전 환자의 포괄적인 관리에 유용한 역할을 합니다.
NT-proBNP는 응급실, 병동, 외래 환경에서 사용됩니다.
안지오텐신 수용체 네프릴리신 억제제(Angiotensin receptor-neprilysin inhibitor, ARNi)의 시대에 NT-proBNP는 치료 모니터링에 있어 BNP보다 유용합니다.